UK
UK
Aug-10
Cardiovascular Pharmacoepidemiology
Read moreJun-10
Cardiovascular Pharmacoepidemiology Women's Health
Read moreMay-10
Cardiovascular Pharmacoepidemiology
Read moreMay-10
Nov-09
Cardiovascular Pharmacoepidemiology
Read moreNov-09
Cardiovascular Pharmacoepidemiology
Read moreAug-09
Jul-09
Cardiovascular Pharmacoepidemiology
Read moreJul-09
Nov-08
Cardiovascular Pharmacoepidemiology
Read moreNov-08
Cardiovascular Pharmacoepidemiology
Read moreSep-08
Cardiovascular Pharmacoepidemiology
Read more| Date | Title | Categories | |
|---|---|---|---|
| Aug-10 | Prescription trends for dopamine agonists in UK primary care – The influence of safety alerts concerning valvular heart disease | Read more | |
| Jun-10 | Individualising the risks of statins in men and women in England and Wales: population-based cohort study | Read more | |
| May-10 | No Association Between the Use of Oral Bisphosphonates and Incidence of Atrial Fibrillation | Read more | |
| May-10 | An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study | Read more | |
| Nov-09 | Discontinuation of Low-dose Acetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes is Associated With an Increased Risk of Myocardial Infarction | Read more | |
| Nov-09 | Discontinuation of Low-dose Acetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes | Read more | |
| Aug-09 | LDL-C Goal Attainment According to Prescribed Lipid-Lowering Therapy: Results from the LIPIDE European Survey | Read more | |
| Jul-09 | Statins in heart failure: Retrospective cohort study using routine primary care data | Read more | |
| Jul-09 | An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study | Read more | |
| Nov-08 | Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population | Read more | |
| Nov-08 | Age threshold for routine aspirin treatment to prevent cardiovascular disease in patients without diabetes | Read more | |
| Sep-08 | Trends in Survival Following Acute Myocardial Infarction in the United Kingdom: Relation to Changes in Prescribing of Evidence-Based Medication in Primary Care | Read more |
